Significance: Many complex diseases are caused by aberrant protein–protein interactions or protein misfolding, which present immense challenges for drug discovery. Here, we present the design, synthesis, and usage of a diverse library of potential pharmacological chaperones that could interfere with undesirable protein–protein interactions and prevent aggregation of misfolded proteins.
23 November 2015 in Angewandte Chemie International Edition